Table 1.
Baseline demographic, clinical and angiographic characteristics of the study groups.
| Control group (n=20) | Abciximab group (n=20) | Tirofiban group (n=20) | P value | |
|---|---|---|---|---|
| Age (years) | 61±10 | 61±10 | 59±10 | 0.23 |
| Women | 4 | 4 | 3 | 0.90 |
| Height (cm) | 175±9 | 176±9 | 177±9 | 0.59 |
| Weight (kg) | 76±12 | 83±16 | 83±12 | 0.49 |
| Active smoker | 9 | 7 | 10 | 0.62 |
| Hypercholesterolaemia | 8 | 6 | 7 | 0.86 |
| Hypertension | 7 | 8 | 7 | 0.93 |
| Diabetes | 1 | 3 | 2 | 0.57 |
| Family history of AMI | 10 | 6 | 10 | 0.34 |
| Previous AMI | 5 | 2 | 4 | 0.46 |
| Multivessel disease | 5 | 7 | 6 | 0.79 |
| Anterior infarction | 14 | 13 | 11 | 0.60 |
| ST shift (mm) | 14±5 | 15±7 | 12.7±3 | 0.47 |
| Number of stents | 1.35±0.5 | 1.1±0.3 | 1.25±0.5 | 0.18 |
| TIMI 0 before PTCA | 15 | 14 | 17 | 0.60 |
| TIMI 3 after PTCA | 19 | 19 | 20 | 0.60 |
| Present thrombus | 13 | 15 | 16 | 0.34 |
| Complex lesions | 15 | 12 | 13 | 0.73 |
| Time to PCI | 191.3±55.75 | 199.1±55.6 | 192.5±49.3 | 0.44 |
Data are presented as the absolute number of patients or mean value ± SD. AMI=acute myocardial infarction, TIMI=thrombolysis in myocardial infarction, PTCA=percutaneous transluminal coronary intervention.